Delivery Order SPE2DB22D3301-SPE2DB25FX9FG
Award Date
1/29/25
Potential Completion Date
1/30/25
Potential Value
$9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of GLYCOPYRROLATE 0.2 MG/ML VIAL 5ML, a pharmaceutical product. The contract has a firm fixed price of $1,168.74 and a period of performance through August 2, 2024. The contract is not set aside for any specific business type. AmerisourceBergen, a large pharmaceutical distributor, has been awarded this delivery order as part of a broader Indefinite Delivery Contract (IDC)...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4565616879 - GLYCOPYRROLATE 0.2 MG/ML VIAL 5ML. The contract has an ultimate completion date of August 29, 2024 and a ceiling value of $15,536.46. The contract is not set aside. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that has been awarded numerous federal contracts to provide a wide range of medical commodities, including specialty...
This is a $1,160.22 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides the DLA with 4,566,945,412 units of the pharmaceutical product glycopyrrolate 1 mg/5 ml vial, 5 ml. The contract has an ultimate completion date of January 16, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,427.42 firm fixed price delivery order is for the supply of 4566136616 - GLYCOPYRROLATE 0.2 MG/ML VIAL 2ML, a medication used for various medical purposes. The contract has an ultimate completion date of October 21, 2024 and was awarded on October 18, 2024. Amerisourcebergen holds a...
This federal contract award, valued at $1,708.45, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of 4565913702 - GLYCOPYRROLATE 4 MG/20 ML VIAL 20ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of September 25, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of 4565978297 GLYCOPYRROLATE 4 MG/20 ML VIAL 20ML. The contract has a ceiling value of $1,398.76 and an ultimate completion date of October 1, 2024. It is a Firm Fixed Price contract with no set-aside designation. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,566,254,915 units of the drug glycopyrrolate 1 mg/5 ml vial with a 5 ml volume. The contract has a ceiling value of $1,495.28 and is a firm fixed-price delivery order with a completion date of September 9, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,442.46, is for the supply of GLYCOPYRROLATE INJECT, a medication, and is a firm fixed-price delivery order with an ultimate completion date of August 15, 2024. The contract has no set-aside designation. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,867.08 firm fixed-price delivery order is for the supply of 4,566,639,791 units of the medication Glycopyrrolate 1 mg/5 ml Vial 5 ml. The contract has a completion date of December 9, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,021.25 under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued at $999,999,999, serves as a vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The specific delivery order is for the purchase of 4563575117...